Medical Alerts

The following Medical Alerts are listed on the National Hemophilia Foundation's website:


Medical Advisory #409 - February 18th, 2009
Signs of Variant Creutzfeldt-Jakob Disease Found in a UK Patient with Hemophilia: No Added Risk Seen for U.S. Patients

Medical Advisory #408 - November 21st, 2008
CSL Behring Initiates Field Correction of Component Packs Packaged with Specific Lots of Mononine

Medical Advisory #407 - August 20th, 2008
CSL Behring Initiates Voluntary Recall of Specific Lots of Monoclate-P

Medical Advisory #406 - November  29, 2006
FDA Confirms Low Risk for Creutzfeldt-Jakob Disease

Medical Advisory #405 - June 9
Novo Nordisk Issues Missing Product Alert

Medical Advisory #404 - February 18
FDA Issues Nationwide Alert for Preloaded Syringes

Medical Advisory #403 - January 18
vCJD Risk Announced for German and Italian users for ZLB product

Medical Advisory #402 - December 7
"Beige Substance" Formation on Certain Butterfly Needles

Medical Advisory #401 - October 14, 2004
vCJD Risk Announced for U.K. Plasma Products

The information contained on the Texas Central Hemophilia Association (TexCen) web site is provided for your general information only. TexCen does not give medical advice or engage in the practice of medicine. TexCen under no circumstances recommends particular treatment for specific individuals and in all cases recommends that you consult your physician or local treatment center before pursuing any course of treatment.